Filtros : "Honorio, Kathia Maria" "Emirados Árabes Unidos" Removidos: "Boletim da Sociedade Astronomica Brasileira" "EESC-SHS" "Indexado no Scielo" "ANALISES CLINICAS E TOXICOLOGICAS" "MACHADO, MARCELLO MARCONDES" "1990" Limpar

Filtros



Refine with date range


  • Source: Frontiers in Drug Discovery. Unidade: EACH

    Assunto: INIBIÇÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SERAFIM, Mateus Sá Magalhães et al. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study. Frontiers in Drug Discovery, v. 3, p. 01-18, 2023Tradução . . Disponível em: https://doi.org/10.3389/fddsv.2023.1237655. Acesso em: 05 jul. 2024.
    • APA

      Serafim, M. S. M., Pantaleão, S. Q., Silva, E. B. da, McKerrow, J. H., O’Donoghue, A. J., Mota, B. E. F., et al. (2023). The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study. Frontiers in Drug Discovery, 3, 01-18. doi:10.3389/fddsv.2023.1237655
    • NLM

      Serafim MSM, Pantaleão SQ, Silva EB da, McKerrow JH, O’Donoghue AJ, Mota BEF, Honorio KM, Maltarollo VG. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study [Internet]. Frontiers in Drug Discovery. 2023 ; 3 01-18.[citado 2024 jul. 05 ] Available from: https://doi.org/10.3389/fddsv.2023.1237655
    • Vancouver

      Serafim MSM, Pantaleão SQ, Silva EB da, McKerrow JH, O’Donoghue AJ, Mota BEF, Honorio KM, Maltarollo VG. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study [Internet]. Frontiers in Drug Discovery. 2023 ; 3 01-18.[citado 2024 jul. 05 ] Available from: https://doi.org/10.3389/fddsv.2023.1237655
  • Source: Current Topics in Medicinal Chemistry. Unidade: EACH

    Assunto: DOENÇA DE CHAGAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARBOSA, Henrique et al. The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021. Current Topics in Medicinal Chemistry, v. 23, n. Ja 2023, p. 159-213, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666221212111514. Acesso em: 05 jul. 2024.
    • APA

      Barbosa, H., Thevenard, F., Reimão, J. Q., Tempone, A. G. T., Honorio, K. M., & Lago, J. H. G. (2023). The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021. Current Topics in Medicinal Chemistry, 23( Ja 2023), 159-213. doi:10.2174/1568026623666221212111514
    • NLM

      Barbosa H, Thevenard F, Reimão JQ, Tempone AGT, Honorio KM, Lago JHG. The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021 [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( Ja 2023): 159-213.[citado 2024 jul. 05 ] Available from: https://doi.org/10.2174/1568026623666221212111514
    • Vancouver

      Barbosa H, Thevenard F, Reimão JQ, Tempone AGT, Honorio KM, Lago JHG. The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021 [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( Ja 2023): 159-213.[citado 2024 jul. 05 ] Available from: https://doi.org/10.2174/1568026623666221212111514

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024